Literature DB >> 16927530

Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.

Jenny Eggenschwiler1, Andrea Patrignani, Ulrich Wagner, Hubert Rehrauer, Ralph Schlapbach, Lukas Rist, Mac H Ramos, Angelika Viviani.   

Abstract

Cytotoxicity assays in vitro (MTT test) showed that the different breast cancer cell lines Kpl-1, MCF-7 and Mfm-223 respond differently to the mistletoe (Viscum album L.) preparations Iscador. Quercus (Qu), Abies (A), Malus (M) and Pinus (P). In order to determine the differences in the responsiveness of the cells more exactly, the gene expression profiles were determined by cells, which were treated with Mistletoe extracts, compared with untreated control cells. Such differences can be analysed in more detail by looking at the gene expression using Human Whole Genome microarray chips (41,000 genes). The results of the transcriptome analyses suggested that Iscador preparations influenced the overregulation of genes regarding immune defense, stress response, apoptosis and cell-cell adhesion pathways. Within the Mfm-223-Zellen was the Genexpression in MCF-7 and Kpl-1. The MCF-7 cells were affected on the genes which are involved in cell-cell contacts whereas Kpl-1 responded to the mistletoe extracts by changing the mRNA levels of the immune and stress response pathways. Concerning the effects of the mistletoe extract, we conclude that Iscador Qu and M have a greater influence on the immune defense and stress response genes whereas Iscador A tends to affect the cell-cell adhesion and cytoskeleton pathways. In summary, cDNA microarray analyses give us information on whether a cancer cell is sensitive to mistletoe extracts in relation to how many genes are significantly overrepresented after mistletoe treatment, and whether a particular mistletoe extract is more effective on a specific cancer cell than the other preparation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927530     DOI: 10.1055/s-0031-1296816

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.

Authors:  M Twardziok; D Meierhofer; S Börno; B Timmermann; S Jäger; Sengül Boral; A Eggert; C I Delebinski; G Seifert
Journal:  BMC Complement Altern Med       Date:  2017-04-28       Impact factor: 3.659

2.  Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.

Authors:  Guo-Shiou Liao; Maria Karmella Apaya; Lie-Fen Shyur
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-12       Impact factor: 2.629

3.  Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).

Authors:  Jenny Eggenschwiler; Leopold von Balthazar; Bianca Stritt; Doreen Pruntsch; Mac Ramos; Konrad Urech; Lukas Rist; A Paula Simões-Wüst; Angelika Viviani
Journal:  BMC Complement Altern Med       Date:  2007-05-10       Impact factor: 3.659

4.  Barriers and challenges in integration of anthroposophic medicine in supportive breast cancer care.

Authors:  Eran Ben-Arye; Elad Schiff; Moti Levy; Orit Gressel Raz; Yael Barak; Gil Bar-Sela
Journal:  Springerplus       Date:  2013-07-31

5.  NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors.

Authors:  Patrick J Mansky; Dawn B Wallerstedt; Timothy S Sannes; Jamie Stagl; Laura Lee Johnson; Marc R Blackman; Jean L Grem; Sandra M Swain; Brian P Monahan
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-27       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.